Medical policy
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
View LCDs
Medicare Administrative Contractors (MAC) develop LCDs to describe circumstances for Medicare coverage for our jurisdictions. There are two ways to view LCDs, either by viewing the list of all active…
View LCDs
Medicare Administrative Contractors (MAC) develop LCDs to describe circumstances for Medicare coverage for our jurisdictions. There are two ways to view LCDs, either by viewing the list of all active…
Proposed LCDs – submit comments
Please view these guidelines for submitting comments on proposed LCDs.
Proposed LCDs – submit comments
Please view these guidelines for submitting comments on proposed LCDs.
Avoid negative impacts to your claims -- review billing and coding article A58918 molecular pathology and genetic testing
View this important information you must know if you bill for molecular pathology and genetic testing. This article was updated April 8.
Bill infectious disease panels correctly
First Coast identified several errors when providers bill for infectious disease panels. Read this article to learn more about billing these services correctly.